Designing improved poly lactic-co-glycolic acid microspheres for a malarial vaccine: Incorporation of alginate and polyinosinic-polycytidilic acid

Journal of Microencapsulation

Volumn 31, Issue 6, 2014, Pages 560-566

  Salvador, Aiala ^a,b   Igartua, Manoli ^a,b   Hernández, Rosa María ^a,b   Pedraz, José Luis ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Alginate; Malaria; Microspheres; PLGA; Poly(I:C)

Indexed keywords

ALGINIC ACID; FREUND ADJUVANT; GLYCOLIC ACID DERIVATIVE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MALARIA VACCINE; MICROSPHERE; POLY LACTIC CO GLYCOLIC ACID MICROSPHERE; POLYINOSINIC POLYCYTIDYLIC ACID; UNCLASSIFIED DRUG; GLUCURONIC ACID; HEXURONIC ACID; IMMUNOGLOBULIN G; INTERFERON INDUCING AGENT; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; PROTOZOON ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; MICROENCAPSULATION; MOUSE; NONHUMAN; SCANNING ELECTRON MICROSCOPY; TH1 TH2 BALANCE; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; IMMUNOLOGY; MALARIA; METABOLISM; MICROBIOLOGY; TH1 CELL; TH2 CELL;

ALGINATES; ANIMALS; ANTIBODIES, PROTOZOAN; FEMALE; GLUCURONIC ACID; HEXURONIC ACIDS; IMMUNOGLOBULIN G; INTERFERON INDUCERS; LACTIC ACID; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; MICROSPHERES; POLY I-C; POLYGLYCOLIC ACID; TH1 CELLS; TH2 CELLS;

EID: 84906535491     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2014.885608     Document Type: Article

References (46)

1. Adame-Gallegos JR, Shi J, McIntosh RS, Pleass RJ. The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii Merozoite Surface Protein 1-19 (MSP119). Exp Parasitol, 2012;130: 384-93
2. Aguilar JC, Rodriguez EG. Vaccine adjuvants revisited. Vaccine, 2007; 25: 3752-62
3. Anilbabu B, Srinivasarao G, Anbu J, Sivakumar L, Sukumaran N, Murugesan R, Sivakumar S, Shanmugarajan T, Ravichandran V. Immune augmentation of single contact hepatitis B vaccine by using PLGA microspheres as an adjuvant. Indian J Pharm Sci, 2008;70: 487-90
4. Babu VR, Patel P, Mundargi RC, Rangaswamy V, Aminabhavi TM. Developments in polymeric devices for oral insulin delivery. Expert Opin Drug Deliv, 2008;5: 403-15
5. Borges O, Silva M, de Sousa A, Borchard G, Junginger HE, Cordeiroda-Silva A. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen. Int Immunopharmacol, 2008;8: 1773-80
6. Carcaboso A, Herńandez R, Igartua M, Rosas J, Patarroyo M, Pedraz J. Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: Single intradermal administration. Pharm Res, 2004;21: 121-6
7. Chaturvedi K, Ganguly K, Nadagouda MN, Aminabhavi TM. Polymeric hydrogels for oral insulin delivery. J Control Release, 2013;165: 129-38
8. Chua BY, Al Kobaisi M, Zeng W, Mainwaring D, Jackson DC. Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive Vaccines. Mol Pharm, 2012;9: 81-90
9. Cui Z, Qiu F. Synthetic double-stranded RNA poly(I: C) as a potent peptide vaccine adjuvant: Therapeutic activity against human cervical cancer in a rodent model. Cancer Immunol Immunother, 2006;55: 1267-79
10. De Gregorio E, DOro U, Wack A. Immunology of TLR-independent vaccine adjuvants. Curr Opin Immunol, 2009;21: 339-45
11. Faisal SM, Yan W, McDonough SP, Chang Y. Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. Vaccine, 2009;27: 378-87
12. Garlapati S, Facci M, Polewicz M, Strom S, Babiuk LA, Mutwiri G, Hancock REW, Elliott MR, Gerdts V. Strategies to link innate and adaptive immunity when designing vaccine adjuvants. Vet Immunol Immunopathol, 2009;128: 184-91
13. Giri TK, Choudhary C, Ajazuddin Alexander A, Badwaik H, Tripathi DK. Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery. Saudi Pharm J, 2013;21: 125-41
14. Giteau A, Venier-Julienne MC, Aubert-Pouëssel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles? Int J Pharm, 2008;350: 14-26
15. Gombotz WR, Wee S. Protein release from alginate matrices. Adv Drug Deliv Rev, 1998;31: 267-85
16. Hafner AM, Corthésy B, Textor M, Merkle HP. Tuning the immune response of dendritic cells to surface-Assembled poly(I: C) on microspheres through synergistic interactions between phagocytic and TLR3 signaling. Vet Immunol Immunopathol, 2011;32: 2651-61
17. Hamdy S, Molavi O, Ma Z, Haddadi A, Alshamsan A, Gobti Z, Elhasi S, Samuel J, Lavasanifar A. Co-delivery of cancer-Associated antigen and toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+T cell-mediated anti-Tumor immunity. Vaccine, 2008;26: 5046-57
18. Hunter RL, Kidd MR, Olsen MR, Patterson PS, Lal AA. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole bloodstage antigens and copolymer adjuvants. J Immunol, 1995;154: 1762-9
19. Jhunjhunwala S, Raimondi G, Thomson AW, Little SR. Delivery of rapamycin to dendritic cells using degradable microparticles. J Control Release, 2009;133: 191-7
20. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, Matsushita K, Hiiragi A, Dermody TS, Fujita T, Akira S. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acidinducible gene-I and melanoma differentiation-Associated gene 5. J Exp Med, 2008;205: 1601-10
21. Kool M, Soullie T, van Nimwegen M, Willart MAM, Muskens F, Jung S, Hoogsteden HC, Hammad H, Lambrecht BN. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med, 2008;205: 869-82
22. Kulkarni AR, Soppimath KS, Aminabhavi TM, Rudzinski WE. In-vitro release kinetics of cefadroxil-loaded sodium alginate interpenetrating network beads. Eur J Pharm Biopharm, 2001;51: 127-33
23. Leclerc L, Rima W, Boudard D, Pourchez J, Forest V, Bin V, Mowat P, Perriat P, Tillement O, Grosseau P, et al. Size of submicrometric and nanometric particles affect cellular uptake and biological activity of macrophages in vitro. Inhal Toxicol, 2012;24: 580-8
24. Li H, Nookala S, Re F. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release. J Immunol, 2007;178: 5271-6
25. Mata E, Carcaboso AM, Herńandez RM, Igartua M, Corradin G, Pedraz JL. Adjuvant activity of polymer microparticles and montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice. Vaccine, 2007;25: 877-85
26. Mata E, Igartua M, Herńandez RM, Rosas JE, Patarroyo ME, Pedraz JL. Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides. Drug Deliv, 2010;17: 490-9
27. Mata E, Igartua M, Patarroyo ME, Pedraz JL, Herńandez RM. Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate. Eur J Pharm Sci, 2011;44: 32-40
28. Matsumoto M, Seya T. TLR3: Interferon induction by double-stranded RNA including poly(I: C). Adv Drug Deliv Rev, 2008;60: 805-12
29. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using Poly(D, L-lactide-co-glycolide) and its derivatives. J Control Release, 2008;125: 193-209
30. Nazarian S, Gargari SLM, Rasooli I, Hasannia S, Pirooznia N. A PLGAencapsulated chimeric protein protects against adherence and toxicity of enterotoxigenic Escherichia coli. Microbiol Res, 2014;162: 205-12
31. O'Hagan DT, MacKichan ML, Singh M. Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng, 2001; 18: 69-85
32. Perrie Y, Mohammed AR, Kirby DJ, McNeil SE, Bramwell VW. Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens. Int J Pharm, 2008;364: 272-80
33. Rice-Ficht AC, Arenas-Gamboa AM, Kahl-McDonagh MM, Ficht TA. Polymeric particles in vaccine delivery. Curr Opin Microbiol, 2010;13: 106-12
34. Rosas JE, Herńandez RM, Gascón AR, Igartua M, Guzman F, Patarroyo ME, Pedraz JL. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Vaccine, 2001;19: 4445-51
35. Salaun B, Greutert M, Romero P. Toll-like receptor 3 is necessary for dsRNA adjuvant effects. Vaccine, 2009;27: 1841-7
36. Salem ML, El-Naggar S, Kadima A, Gillanders WE, Cole DJ. The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I: C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu. Vaccine, 2006;24: 5119-32
37. Salvador A, Hernandez RM, Pedraz JL, Igartua M. Plasmodium falciparum malaria vaccines: Current status, pitfalls and future directions. Expert Rev Vacc, 2012a;11: 1071-86
38. Salvador A, Igartua M, Hernandez RM, Pedraz JL. Combination of immune stimulating adjuvants with poly(lactide-co-glycolide) microspheres enhances the immune response of vaccines. Vaccine, 2012b; 30: 589-96
39. Salvador A, Igartua M, Pedraz JL, Herńandez RM. 2012c. Dendritic cells interactions with the immune system-Implications for vaccine development. In: Gowder S, ed. Cell interaction. USA Intech, pp. 69-92
40. Sauerwein RW. Clinical malaria vaccine development. Immunol Lett, 2009;122: 115-17
41. Sharp FA, Ruane D, Claass B, Creagh E, Harris J, Malyala P, Singh M, O'Hagan DT, Pétrilli V, Tschopp J, et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci USA, 2009;106: 870-5
42. Soppimath KS, Aminabhavi TM. Ethyl acetate as a dispersing solvent in the production of poly(DL-lactide-co-glycolide) microspheres: Effect of process parameters and polymer type. J Microencapsul, 2002;19: 281-92
43. Verdijk RM, Mutis T, Esendam B, Kamp J, Melief CJM, Brand A, Goulmy E. Polyriboinosinic polyribocytidylic acid (poly(I: C)) induces stable maturation of functionally active human dendritic cells. J Immunol, 1999;163: 57-61
44. Walter E, Dreher D, Kok M, Thiele L, Kiama SG, Gehr P, Merkle HP. Hydrophilic poly(lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. J Control Release, 2001;76: 149-68
45. Wischke C, Zimmermann J, Wessinger B, Schendler A, Borchert H, Peters JH, Nesselhut T, Lorenzen DR. Poly(I: C) coated PLGA microparticles induce dendritic cell maturation. Int J Pharm, 2009; 365: 61-8
46. Zheng C, Gao J, Zhang Y, Liang W. A protein delivery system: Biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres. Biochem Biophys Res Commun, 2004;323: 1321-7